Travere Therapeutics, Inc. - Common Stock (TVTX)
17.87
-0.22 (-1.22%)
Travere Therapeutics is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare diseases, particularly those associated with kidney disorders
The company’s mission is to address significant unmet medical needs and improve the quality of life for individuals affected by these conditions. By leveraging advanced research and development capabilities, Travere aims to deliver targeted treatments that can help manage or potentially reshape the course of rare kidney diseases, ultimately striving to empower patients and their families through effective therapeutic options.
